Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Electronics Contract Manufacturers Are Riding These Bullish Trends
03:23pm, Thursday, 10'th Nov 2022
Electronics manufacturing services are center stage for a host of growth trends from reshoring of production to the boom in electric vehicles. The post Electronics Contract Manufacturers Are Riding Th
Better Buy: Johnson & Johnson vs. Abbott Laboratories
09:37am, Thursday, 10'th Nov 2022
These two healthcare giants are among the safest stocks investors can buy right now.
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
08:37am, Thursday, 10'th Nov 2022
The company is planting seeds for future growth.
2 Healthcare Stocks That Could Help Make You a Fortune
08:15am, Thursday, 10'th Nov 2022
These two stocks are both great fits for a dividend stock portfolio.
5 Top Dividend Stocks Investors Should Never Sell
05:06am, Wednesday, 09'th Nov 2022
These top-notch income stocks, which range in yield from 1.8% to 7.6%, are as rock solid as they come.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
10:07am, Tuesday, 08'th Nov 2022
These robust businesses will be around well beyond the next 10 years.
Johnson & Johnson: Steady Growth Play
03:53am, Monday, 07'th Nov 2022
Johnson & Johnson has steadily been growing the business. After having deleveraged its balance sheet, the company announced a $16.6 billion deal for Abiomed.
Johnson & Johnson's Big Purchase, Amazon's New Moves, and More
10:45am, Saturday, 05'th Nov 2022
Plus, we run through some shortcuts that could help you with your financial planning.
3 No-Brainer Dividend Stocks to Buy in November
09:31am, Saturday, 05'th Nov 2022
There's no need for agonizing decision-making with these great dividend stocks.
Is Johnson & Johnson's Purchase of Abiomed Good for Investors?
07:25am, Saturday, 05'th Nov 2022
The $16.6 billion acquisition shakes up MedTech.
Beat the Dow Jones With This Unstoppable Dividend Stock
06:00am, Saturday, 05'th Nov 2022
Johnson & Johnson has outperformed the Dow so far this year.
3 Dividend Kings Crushing the S&P 500 in 2022
04:33pm, Friday, 04'th Nov 2022
Companies in the Dividend King club carry well-established and successful business operations, clearly displayed by their commendable commitment to shareholders over decades of increased dividend payo
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
10:32am, Friday, 04'th Nov 2022
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
GSK's Q3 Earnings Beat, Ups 2022 Sales Outlook, Stock Up
02:18pm, Wednesday, 02'nd Nov 2022
GSK's (GSK) revenues benefit from the strong growth in sales across all segments. The company raises the full-year sales guidance for all its segment
Johnson & Johnson Goes Back Into Cardiology With A Big Splash
11:46am, Wednesday, 02'nd Nov 2022
JNJ announced the $16.6 billion-plus acquisition of Abiomed, agreeing to pay $380/share in cash upfront and up to $35/share tied to longer-term performance targets. Abiomed sells heart pumps that assi
